Tag | Content |
---|
EnhancerAtlas ID | HS146-06434 |
Organism | Homo sapiens |
Tissue/cell | NHDF |
Coordinate | chr17:40066540-40067630 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MYC | MA0147.3 | chr17:40067564-40067576 | AGCCACGTGCTC | + | 6.04 | NFE2L1 | MA0089.2 | chr17:40067132-40067147 | ACTGCTGAGTCAGGG | - | 6.15 | NR2C2 | MA0504.1 | chr17:40066714-40066729 | TGCCCTTTCACCCCT | - | 6.4 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_65441 | chr17:40061459-40069226 | Pancreatic_islets |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH17I041904 | chr17 | 40060936 | 40068122 |
|
Enhancer Sequence | CAGAAAAATT GAGGGAGATG AAACTCAGAG GGACAGCACG TCTTGCCCCT AGGGCAGAAG 60 GAGGGACTGC ACAGGGGTGG TGCCCAAGCA CTCCCACCAC CACACCCAGC AAAGAGAGAT 120 TTTTCCAGAA AAAATGGGGT CACAGATCCC TAAGCTCAGT AAGTCCTCAG GAGATGCCCT 180 TTCACCCCTT GCTCTGGTGC GGGCTGTGCC TGAACAGGCA CCGACCTTGC CCACTCTTGG 240 CCTCCTCTGG AGGGTGACAC AGGACCTGCG CAAGTGAAAG GGCTCCAACA AGTCACGGCT 300 GTGGCAGAGC TTGACGGGGA GGGGAAACCG GGTAGAAGGG AGGTAACCAT TCTGCTTCAT 360 GAGCCTTGAG GAAGGCACAG TGACTCAGCC TCAGGACATG GGTCCGGGCG CAGGGAATGG 420 GTGGAGAAGT GGGGAGCCAG GGCTTAATCA GGGAAACTTC TCCACGCAGA CTCTCCTGGC 480 TGAGGACCAC AGGCCTGCAG AGCTAATCAG TTCGAGTGAT TCCCTGGCGG CGGCTGTGGC 540 GAGACAGCCC TCATCCTAGT AAGTCCCAAA ACCCCCGCCT GGCCTGTGCG TCACTGCTGA 600 GTCAGGGACC AGACAGCAAT CCATAAGAGG TAATGAGCCA CTCCTGCTGG CCCAACGCTG 660 CTGCCAGCTC AGATGTCTGA TGTCCCACCT TCCCCTCCCA GAGGCCAGCA GAAGGAAGCA 720 GGATGTGCTC CCTGGGGACA TGCTCAGCAT CCCTCCCTCC AATCCCACCA TCCTCTCTCC 780 AAAGGCCTGG GAACTCAAGG GACAGGTCGC TTCACGCCTG GGTCCATGTG CAACTTCAAG 840 GATCCCGCTT TACCCATGAG GGCCAGAAAC TGGGAAATTA ACATTTAAGG GCTACTCTGA 900 GGAAGCCCAA TGAGGGAGGA AGACATCTCC ATCACCACCT TCATTGCTAT TCTCGAGGCA 960 GCCAAGGAAG AGAACAGCTC ATCCCTGGTA CAGTTTCACC CCAGATGAGC ACCAGGCCCT 1020 TCAGAGCCAC GTGCTCTACA GAGCCAGGTG TGGATGGCAC ATTCTTCCCA GGCTAGGCCA 1080 GGCCTCAGCT 1090
|